Related Experiment Video
Updated: Mar 5, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Mechanistic and therapeutic perspectives for cardiac arrhythmias: beyond ion channels
Yufei Wu1,2,3, Jun Li1,2,3, Liang Xu1,2
1Key Laboratory of Arrhythmias of the Ministry of Education of China, Tongji University, Shanghai, 200092, China.
Insights
Cardiac arrhythmias, a leading cause of death, involve more than just ion channel defects. This review explores new cellular mechanisms and discusses developing safer, more effective antiarrhythmic treatments.
Area of Science:
- Cardiology
- Molecular Biology
- Cellular Biology
Background:
- Cardiac arrhythmias are a major global health concern and a leading cause of mortality worldwide.
- While ion channel disorders are recognized causes of arrhythmias, they do not explain all cases.
- Current antiarrhythmic drugs have limited efficacy and can cause proarrhythmic effects.
Purpose of the Study:
- To review novel cellular mechanisms underlying cardiac arrhythmias.
- To focus on the role of subcellular organelle dysfunction and intracellular transport in arrhythmia development.
- To discuss potential strategies and challenges for developing new antiarrhythmic therapies.
Main Methods:
- Literature review of foundational and recent studies on cardiac arrhythmias.
- Analysis of cellular and molecular mechanisms contributing to arrhythmia.
- Discussion of therapeutic targets related to organelle function and intracellular logistics.
Main Results:
- Identified dysfunction of subcellular organelles (e.g., sarcoplasmic reticulum, mitochondria) as key contributors to arrhythmias.
- Highlighted the importance of intracellular logistics, including protein trafficking and calcium handling, in maintaining cardiac rhythm.
- Emphasized that non-ion channel defects are significant factors in arrhythmia pathogenesis.
Conclusions:
- Cardiac arrhythmias result from complex cellular dysfunctions beyond simple ion channel mutations.
- Targeting subcellular organelles and intracellular transport pathways offers promising avenues for novel antiarrhythmic drug development.
- Future research should focus on these novel mechanisms to create safer and more effective treatments for arrhythmias.
Abstract:
Cardiac arrhythmias are among the most common causes of death in the world. Foundational studies established the critical role of ion channel disorders in arrhythmias, yet defects in ion channels themselves, such as mutations, may not account for all arrhythmias. Despite the progress made in recent decades, the antiarrhythmic drugs currently available have limited effectiveness, and the majority of these drugs can have proarrhythmic effects. This review describes novel knowledge on cellular mechanisms that cause cardiac arrhythmias, focuses on the dysfunction of subcellular organelles and intracellular logistics, and discusses potential strategies and challenges for developing novel, safe and effective treatments for arrhythmias.
More Related Videos
08:43Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
Published on: August 26, 2021
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Electrophysiology of Normal Cardiac Rhythm